FRANK E THOMAS Insider Trading $AVM AMAG PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FRANK E THOMAS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FRANK E THOMAS. FRANK E THOMAS is EVP, Chief Operating Officer in AMAG PHARMACEUTICALS INC. ($AVM) and President & COO in AMAG PHARMACEUTICALS INC. ($AVM) and VP, Finance & CFO in ESPERION THERAPEUTICS INC/MI ($ESPR) and Director in ZAFGEN, INC. ($ZFGN) and Director in Spero Therapeutics, Inc. ($SPRO) and See Remarks in Orchard Therapeutics plc ($ORTX).
FRANK E THOMAS in AMAG PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANK E THOMAS: President & COO, EVP, Chief Operating Officer
Holdings: 126,195 shares
Latest Transaction: Feb 27 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FRANK E THOMAS in AMAG PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVM, ESPR, LRMR, ORTX, SPRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Option Exercise | A | 23.75 | 30,000 | 712,500 | 30,000 | |
| Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Grant | A | 0.00 | 12,000 | 0 | 138,195 | 126.2 K to 138.2 K (+9.51 %) |
| Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Grant | A | 0.00 | 12,000 | 0 | 126,195 | 114.2 K to 126.2 K (+10.51 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Option Exercise | A | 25.18 | 40,000 | 1,007,200 | 40,000 | |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Grant | A | 0.00 | 17,000 | 0 | 114,195 | 97.2 K to 114.2 K (+17.49 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 26.28 | 515 | 13,534 | 97,195 | 97.7 K to 97.2 K (-0.53 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 27.01 | 458 | 12,371 | 97,710 | 98.2 K to 97.7 K (-0.47 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 27.01 | 1,361 | 36,761 | 98,168 | 99.5 K to 98.2 K (-1.37 %) |
| Mar 01 2016 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 27.01 | 7,417 | 200,333 | 99,529 | 106.9 K to 99.5 K (-6.94 %) |
| Aug 21 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Payment of Exercise | F | 61.71 | 2,363 | 145,821 | 106,946 | 109.3 K to 106.9 K (-2.16 %) |
| Aug 07 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Option Exercise | M | 14.91 | 15,000 | 223,650 | 45,000 | |
| Aug 07 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Sell | S | 66.85 | 15,000 | 1,002,750 | 109,309 | 124.3 K to 109.3 K (-12.07 %) |
| Aug 07 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Buy | M | 14.91 | 15,000 | 223,650 | 124,309 | 109.3 K to 124.3 K (+13.72 %) |
| Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Sell | S | 69.76 | 7,996 | 557,801 | 109,309 | 117.3 K to 109.3 K (-6.82 %) |
| Jun 08 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | President & COO | Sell | S | 69.27 | 12,004 | 831,517 | 117,305 | 129.3 K to 117.3 K (-9.28 %) |
| Mar 05 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Payment of Exercise | F | 49.70 | 4,279 | 212,666 | 129,309 | 133.6 K to 129.3 K (-3.20 %) |
| Feb 27 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Option Exercise | A | 49.46 | 25,000 | 1,236,500 | 25,000 | |
| Feb 27 2015 | AVM | AMAG PHARMACEUTICA ... | THOMAS FRANK E | EVP, Chief Operatin ... | Grant | A | 0.00 | 12,500 | 0 | 133,588 | 121.1 K to 133.6 K (+10.32 %) |
Page: 1